NPF Primer: GLP-1s Worth Considering as Adjunct for Select Psoriasis Patients

(MedPage Today) -- GLP-1 receptor agonists represent a "biologically plausible and clinically intriguing adjunct" to psoriasis therapy for selected patients, authors of a National Psoriasis Foundation (NPF) "primer" concluded. The evidence showed...
Source
MedPage Today
Opens original article in a new tab



